⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

Health & Wellness ETF (BFIT) Hits New 52-Week High

Published 05/31/2018, 09:00 PM
Updated 07/09/2023, 06:31 AM
BFIT
-

For investors seeking momentum, Global X Health & Wellness Thematic ETF (AS:BFIT) is probably on radar now. The fund just hit a 52-week high and is up nearly 18.2% from its 52-week low price of $15.68/share.

But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.

BFIT in Focus

This ETF tracks the Indxx Global Health & Wellness Thematic Index, which measures the performance of companies in developed markets that provide products and services aimed at promoting physical wellness. Dexcom, Lululemon Athletica and Puma SE are the top three stocks of the fund.

Apparel, Accessories & Luxury (22.1%), Footwear (19.8%) and Packaged Foods & Meats (17.1%) are the top three industries. United States (39.5%), Japan (15.0%) and Canada (7.8%) are the top three geographies of the fund. The product charges 50 bps in fees (see all Consumer Discretionary ETFs here).

Why the Move?

People are becoming more health conscious. Millennials – gradually turning out to be the backbone of the U.S. economy – are currently the driving factor behind organic produce sales. Per a research report, the Health and Wellness industry in the United States makes over $153 billion a year, which represents a quarter of the global sales. The market has grown at a steady rate of 5% and has brighter prospect.

More Gains Ahead?

It seems that the fund will perform decently in the near term given a positive weighted alpha of 19.70. Some of the segments that make up this ETF do have strong Zacks Industry Ranks.

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>



GLBL-X H&W THM (BFIT): ETF Research Reports

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.